Lamosaic India Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 16, 2026

Key Highlights

The Latest Trading Price of Lamosaic India Ltd is ₹ 24 as of 16 Mar 13:59 . The P/E Ratio of Lamosaic India Ltd changed from 17 on March 2025 to 17 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Sheel Biotech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Lamosaic India Ltd changed from ₹ 42.28 crore on March 2025 to ₹ 42.28 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Sheel Biotech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The Dividend Payout of Lamosaic India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 14.05 % on March 2025 . This represents a CAGR of -16.18% over 4 years .

About Lamosaic India Ltd

Lamosaic India Limited was originally formed as a Partnership Firm pursuant to Deed of Partnership dated January 07, 2020 in the name and style of 'Swastik Marketing', thereafter the Firm converted its running business from Partnership Firm to a Public Limited Company with the name and style of 'Lamosaic India Limited' and received a Certificate of Incorporation from the Registrar of Companies, Pune dated June 13, 2023. The Company is engaged into plywood and lamination industry.
It is into trading of decorative laminates, acrylic sheets, printing paper (base), plywood and others.
Additionally, to expand the business, it got into manufacturing of flush door and other customized products from September 2023.
Apart from this, it provides a one stop customized solutions i.e.; right from designing to manufacturing to supplying flush doors and laminated products.

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of Lamosaic India Ltd and Sheel Biotech Ltd

Which company has a larger market capitalization, Lamosaic India Ltd or Sheel Biotech Ltd?

Market cap of Lamosaic India Ltd is 25 Cr while Market cap of Sheel Biotech Ltd is 111 Cr

What are the key factors driving the stock performance of Lamosaic India Ltd and Sheel Biotech Ltd?

The stock performance of Lamosaic India Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lamosaic India Ltd and Sheel Biotech Ltd?

As of March 16, 2026, the Lamosaic India Ltd stock price is INR ₹24.75. On the other hand, Sheel Biotech Ltd stock price is INR ₹54.8.

How do dividend payouts of Lamosaic India Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of Lamosaic India Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.